LUCD logo

Lucid Diagnostics Inc. (LUCD)

Profile

Full Name

Lucid Diagnostics Inc.

Ticker

NASDAQ: LUCD

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

October 14, 2021

Indexes

Not included

Website

https://www.luciddx.com

Employees

72

Key Details

Price

$1.26(+5.00%)

Market cap

$128.39M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.35M(+79.00% YoY)

Annual EPS

-$1.05(+16.67% YoY)

PE ratio

-

Next earnings date

Nov 12, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.26
    LUCD price is $1.26

    30-Day Relative Volume

    1.39
    LUCD 30-day relative volume is 1.39

    Price Performance

    Price Most recent change

    +5%
    LUCD price was up +5% on Aug 29, 2025

    Price YTD change

    +53.85%
    LUCD price is up +53.85% since January 1st

    Price 1-year change

    +57.89%
    LUCD price is up +57.89% year-on-year

    Price 3-year change

    -44.49%
    LUCD price is down -44.49% over the past 3 years

    Price Range

    Price All-time high

    $13.52
    LUCD price is currently -90.68% below its historical high of $13.52

    Price 3-year low

    $0.63
    LUCD price is currently +100.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $128.39M
    LUCD market capitalization is $128.39 million

    Market cap 3-year change

    +46.64%
    LUCD market capitalization is up +46.64% over the past 3 years

    Market cap All-time high

    $435.03M
    LUCD market capitalization is currently -70.49% below its historical high of $435.03 million

    Market cap sector rank

    45.27%
    LUCD market capitalization is higher than 45.27% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +106.49%
    LUCD shares outstanding is up +106.49% year-on-year

    Shares Outstanding 3-Year Change

    +164.19%
    LUCD shares outstanding is up +164.19% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.63
    LUCD beta is 0.63

    200-day SMA

    $1.15
    LUCD price is currently +9.80% above its 200-day simple moving average

    50-day SMA

    $1.09
    LUCD price is currently +15.26% above its 50-day simple moving average

    RSI

    68.26
    LUCD 14-day relative strength index is 68.26

    Volume

    1.39
    LUCD 30-day relative volume is 1.39

    ATR

    $0.07
    LUCD average true range is $0.07

    10-day Historical Volatility

    58.95%
    LUCD 10-day historical volatility is 58.95%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.35M
    LUCD annual revenue is $4.35 million

    Revenue Analysts estimate

    $4.88M
    LUCD annual revenue is currently -10.89% lower than the consensus analysts' forecast

    Revenue 1-year change

    +79%
    LUCD annual revenue is up +79% year-on-year

    Revenue Sector rank

    42.8%
    LUCD annual revenue is higher than 42.8% of companies in Healthcare sector

    EPS

    EPS

    -$1.05
    LUCD annual earnings per share is -$1.05

    EPS Analysts estimate

    -$0.46
    LUCD annual earnings per share is currently +130.77% higher than the consensus analysts' forecast

    EPS 1-year change

    +16.67%
    LUCD annual earnings per share is up +16.67% year-on-year

    EPS Sector rank

    51.33%
    LUCD annual earnings per share is higher than 51.33% of companies in Healthcare sector

    Profit

    Gross profit

    -$3.92M
    LUCD annual gross profit is -$3.92 million

    Gross margin

    -90.20%
    LUCD annual gross profit margin is -90.20%

    Operating profit

    -$46.05M
    LUCD annual operating income is -$46.05 million

    Operating margin

    -1059.64%
    LUCD annual operating profit margin is -1059.64%

    Net income

    -$45.53M
    LUCD annual net profit is -$45.53 million

    Net margin

    -1047.61%
    LUCD annual net profit margin is -1047.61%

    Expenses

    Total expenses

    $49.88M
    LUCD annual total expenses is $49.88 million

    Operating expenses

    $42.13M
    LUCD annual total operating expenses is $42.13 million

    Cost of goods sold

    $8.27M
    LUCD annual cost of goods sold is $8.27 million

    Selling, general & administrative expenses

    $0.00
    LUCD annual SGA is $0.00

    Depreciation and amortization

    $1.17M
    LUCD annual depreciation & amortization is $1.17 million

    Interest expense

    $0.00
    LUCD annual interest expense is $0.00

    Income tax

    $0.00
    LUCD annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$46.05M
    LUCD annual earnings before interest & taxes is -$46.05 million

    EBITDA

    -$44.88M
    LUCD annual EBITDA is -$44.88 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $30.71M
    LUCD annual total assets is $30.71 million

    Non current assets

    $5.57M
    LUCD annual long term assets is $5.57 million

    Current assets

    $25.15M
    LUCD annual total current assets is $25.15 million

    Cash and cash equivalents

    $22.36M
    LUCD annual cash & cash equivalents is $22.36 million

    Accounts receivable

    $45.00K
    LUCD annual accounts receivable is $45.00 thousand

    Inventory

    $922.00K
    LUCD annual inventory is $922.00 thousand

    Liabilities

    Total liabilities

    $25.32M
    LUCD annual total liabilities is $25.32 million

    Long term liabilities

    $1.80M
    LUCD annual total long term liabilities is $1.80 million

    Current liabilities

    $23.52M
    LUCD annual total current liabilities is $23.52 million

    Accounts payable

    $1.24M
    LUCD annual accounts payable is $1.24 million

    Debt

    Total debt

    $21.25M
    LUCD annual total debt is $21.25 million

    Total debt 1-year change

    +39.32%
    LUCD annual total debt is up +39.32% year-on-year

    Long term debt

    $1.80M
    LUCD annual long term debt is $1.80 million

    Short term debt

    $19.45M
    LUCD annual short term debt is $19.45 million

    Equity & Capital

    Shareholders equity

    $5.39M
    LUCD annual stockholders equity is $5.39 million

    Book value

    -$49.03M
    LUCD annual book value is -$49.03 million

    Retained earnings

    -$203.77M
    LUCD annual retained earnings is -$203.77 million

    Working capital

    $1.62M
    LUCD annual working capital is $1.62 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$44.14M
    LUCD annual cash flow from operations is -$44.14 million

    Cash from operations 1-year change

    -34.5%
    LUCD annual cash flow from operations is down -34.5% year-on-year

    Cash from investing

    -$646.00K
    LUCD annual cash flow from investing activities is -$646.00 thousand

    Cash from investing 1-year change

    -192.31%
    LUCD annual cash flow from investing activities is down -192.31% year-on-year

    Cash from financing

    $48.25M
    LUCD annual cash flow from financing activities is $48.25 million

    Cash from financing 1-year change

    +63.77%
    LUCD annual cash flow from financing activities is up +63.77% year-on-year

    CAPEX

    CAPEX

    $646.00K
    LUCD annual capital expenditures is $646.00 thousand

    CAPEX 1-year change

    +192.31%
    LUCD annual capital expenditures is up +192.31% year-on-year

    Free Cash Flow

    Free cash flow

    -$44.79M
    LUCD annual free cash flow is -$44.79 million

    Free cash flow 1-year change

    -35.56%
    LUCD annual free cash flow is down -35.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -90.20%
    LUCD annual gross profit margin is -90.20%

    Operating margin

    -1059.64%
    LUCD annual operating profit margin is -1059.64%

    Net margin

    -1047.61%
    LUCD annual net profit margin is -1047.61%

    ROA & ROE

    ROA

    -157.04%
    LUCD annual return on assets is -157.04%

    ROE

    -2956.43%
    LUCD annual return on equity is -2956.43%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    LUCD price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    LUCD price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.76
    LUCD price to book ratio is -2.76

    PB ratio Sector rank

    7.65%
    LUCD price to book ratio is higher than 7.65% of companies in Healthcare sector

    PS Ratio

    PS ratio

    29.45
    LUCD price to sales ratio is 29.45

    PS ratio Sector rank

    83.93%
    LUCD price to sales ratio is higher than 83.93% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $124.82M
    LUCD enterprise value is $124.82 million

    Enterprise value Sector rank

    50.63%
    LUCD enterprise value is higher than 50.63% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.65
    LUCD EV/EBITDA is -2.65

    EV/EBITDA Sector rank

    31.86%
    LUCD EV/EBITDA is higher than 31.86% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.07
    LUCD annual current ratio is 1.07

    Quick ratio

    1.03
    LUCD annual quick ratio is 1.03

    Leverage

    Debt to equity

    3.94
    LUCD annual debt to equity ratio is 3.94

    Interest coverage ratio

    -
    LUCD annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    4
    LUCD piotroski f-score is 4

    Altman Z-Score

    -10.99
    LUCD altman z-score is -10.99

    Analyst ratings

    Recent major analysts updates

    Aug 13, 25 Needham
    Buy
    Jul 16, 25 Needham
    Buy
    Jun 6, 25 Ascendiant Capital
    Buy
    May 15, 25 Cantor Fitzgerald
    Overweight
    May 14, 25 Needham
    Buy
    Apr 21, 25 Ascendiant Capital
    Buy
    Apr 11, 25 Needham
    Buy
    Mar 26, 25 Cantor Fitzgerald
    Overweight
    Mar 24, 25 Needham
    Buy
    Dec 9, 24 Ascendiant Capital
    Buy

    Institutional Ownership

    Screeners with LUCD included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    • What is the ticker symbol for Lucid Diagnostics Inc.?
    • Does Lucid Diagnostics Inc. pay dividends?
    • What sector is Lucid Diagnostics Inc. in?
    • What industry is Lucid Diagnostics Inc. in?
    • What country is Lucid Diagnostics Inc. based in?
    • When did Lucid Diagnostics Inc. go public?
    • Is Lucid Diagnostics Inc. in the S&P 500?
    • Is Lucid Diagnostics Inc. in the NASDAQ 100?
    • Is Lucid Diagnostics Inc. in the Dow Jones?
    • When was Lucid Diagnostics Inc.'s last earnings report?
    • When does Lucid Diagnostics Inc. report earnings?

    What is the ticker symbol for Lucid Diagnostics Inc.?

    The ticker symbol for Lucid Diagnostics Inc. is NASDAQ:LUCD

    Does Lucid Diagnostics Inc. pay dividends?

    No, Lucid Diagnostics Inc. does not pay dividends

    What sector is Lucid Diagnostics Inc. in?

    Lucid Diagnostics Inc. is in the Healthcare sector

    What industry is Lucid Diagnostics Inc. in?

    Lucid Diagnostics Inc. is in the Medical Devices industry

    What country is Lucid Diagnostics Inc. based in?

    Lucid Diagnostics Inc. is headquartered in United States

    When did Lucid Diagnostics Inc. go public?

    Lucid Diagnostics Inc.'s initial public offering (IPO) was on October 14, 2021

    Is Lucid Diagnostics Inc. in the S&P 500?

    No, Lucid Diagnostics Inc. is not included in the S&P 500 index

    Is Lucid Diagnostics Inc. in the NASDAQ 100?

    No, Lucid Diagnostics Inc. is not included in the NASDAQ 100 index

    Is Lucid Diagnostics Inc. in the Dow Jones?

    No, Lucid Diagnostics Inc. is not included in the Dow Jones index

    When was Lucid Diagnostics Inc.'s last earnings report?

    Lucid Diagnostics Inc.'s most recent earnings report was on August 13, 2025

    When does Lucid Diagnostics Inc. report earnings?

    The next expected earnings date for Lucid Diagnostics Inc. is November 12, 2025
    On this page